BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 34374921)

  • 1. Differences in the relationship between diabetes and prostate cancer among Black and White non-Hispanic men.
    Miller EA; Pinsky PF; Pierre-Victor D
    Cancer Causes Control; 2021 Dec; 32(12):1385-1393. PubMed ID: 34374921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the relationship between diabetes and prostate cancer through changes in screening guidelines.
    Miller EA; Pinsky PF
    Cancer Causes Control; 2020 Dec; 31(12):1105-1113. PubMed ID: 32970300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial/Ethnic Disparities in Prostate Cancer Incidence, Distant Stage Diagnosis, and Mortality by U.S. Census Region and Age Group, 2012-2015.
    Iyengar S; Hall IJ; Sabatino SA
    Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1357-1364. PubMed ID: 32303533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation.
    Kensler KH; Pernar CH; Mahal BA; Nguyen PL; Trinh QD; Kibel AS; Rebbeck TR
    J Natl Cancer Inst; 2021 Jun; 113(6):719-726. PubMed ID: 33146392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial disparities in breast cancer hereditary risk assessment referrals.
    Peterson JM; Pepin A; Thomas R; Biagi T; Stark E; Sparks AD; Johnson K; Kaltman R
    J Genet Couns; 2020 Aug; 29(4):587-593. PubMed ID: 32196827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial differences in prostate-specific antigen-based prostate cancer screening: State-by-state and region-by-region analyses.
    Jindal T; Kachroo N; Sammon J; Dalela D; Sood A; Vetterlein MW; Karabon P; Jeong W; Menon M; Trinh QD; Abdollah F
    Urol Oncol; 2017 Jul; 35(7):460.e9-460.e20. PubMed ID: 28256311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Prostate Cancer Incidence Rates and Prevalence of Prostate Specific Antigen Screening by Socioeconomic Status and Regions in the United States, 2004 to 2013.
    Houston KA; King J; Li J; Jemal A
    J Urol; 2018 Mar; 199(3):676-682. PubMed ID: 28965781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer.
    Miller EA; Pinsky PF; Pierre-Victor D
    Cancer Causes Control; 2018 Oct; 29(10):907-914. PubMed ID: 30094676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in suicide rates by race and ethnicity among members of the United States Army.
    Brenner LA; Forster JE; Walsh CG; Stearns-Yoder KA; Larson MJ; Hostetter TA; Hoffmire CA; Gradus JL; Adams RS
    PLoS One; 2023; 18(1):e0280217. PubMed ID: 36649302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing relationship between socioeconomic status and prostate cancer incidence.
    Liu L; Cozen W; Bernstein L; Ross RK; Deapen D
    J Natl Cancer Inst; 2001 May; 93(9):705-9. PubMed ID: 11333293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation.
    Beebe-Dimmer JL; Ruterbusch JJ; Cooney KA; Bolton A; Schwartz K; Schwartz AG; Heath E
    Cancer Med; 2019 Jun; 8(6):3325-3335. PubMed ID: 31094098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California.
    Cheng I; Witte JS; McClure LA; Shema SJ; Cockburn MG; John EM; Clarke CA
    Cancer Causes Control; 2009 Oct; 20(8):1431-40. PubMed ID: 19526319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Leitzmann MF; Ahn J; Albanes D; Hsing AW; Schatzkin A; Chang SC; Huang WY; Weiss JM; Danforth KN; Grubb RL; Andriole GL;
    Cancer Causes Control; 2008 Dec; 19(10):1267-76. PubMed ID: 18618278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and Ethnic Differences in Health Behaviors and Preventive Health Services Among Prostate Cancer Survivors in the United States.
    Li J; Thompson TD; Richards TB; Steele CB
    Prev Chronic Dis; 2016 Jul; 13():E95. PubMed ID: 27442995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes and prostate cancer screening in black and white men.
    Sanderson M; Fowke JH; Lipworth L; Han X; Ukoli F; Coker AL; Blot WJ; Hargreaves MK
    Cancer Causes Control; 2013 Oct; 24(10):1893-9. PubMed ID: 23860952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial/ethnic disparities in maternal oral health experiences in 10 states, pregnancy risk assessment monitoring system, 2004-2006.
    Hwang SS; Smith VC; McCormick MC; Barfield WD
    Matern Child Health J; 2011 Aug; 15(6):722-9. PubMed ID: 20652385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of increasing detection in the rising incidence of prostate cancer.
    Potosky AL; Miller BA; Albertsen PC; Kramer BS
    JAMA; 1995 Feb; 273(7):548-52. PubMed ID: 7530782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing health disparities: medical advice received for minorities with diabetes.
    Vaccaro JA; Huffman FG
    J Health Hum Serv Adm; 2012; 34(4):389-417. PubMed ID: 22530284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in magnetic resonance imaging of the prostate for traditionally underserved patients with prostate cancer.
    Quinn TP; Sanda MG; Howard DH; Patil D; Filson CP
    Cancer; 2021 Aug; 127(16):2974-2979. PubMed ID: 34139027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.